CDA | Evidence Driven
CDA | Evidence Driven

Human Leukocyte Antigen B27 for the Detection of Spondyloarthropathy

Details

Files
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1546-000

Question

  1. What is the diagnostic accuracy of human leukocyte antigen B27 testing for the detection of spondyloarthropathy in patients with low back pain and no other symptoms?
  2. What is the clinical effectiveness of human leukocyte antigen B27 testing for the detection of spondyloarthropathy in patients with low back pain and no other symptoms?
  3. What are the evidence-based guidelines for human leukocyte antigen B27 testing for the detection of spondyloarthropathy in patients with low back pain and no other symptoms?

Key Message

No evidence was identified regarding the diagnostic accuracy of human leukocyte antigen B27 testing for the detection of spondyloarthropathy in patients with low back pain and no other symptoms. No evidence was identified regarding the clinical effectiveness of human leukocyte antigen B27 testing for the detection of spondyloarthropathy in patients with low back pain and no other symptoms. No evidence-based guidelines were identified regarding human leukocyte antigen B27 testing for the detection of spondyloarthropathy in patients with low back pain and no other symptoms.

Files

Human Leukocyte Antigen B27 for the Detection of Spondyloarthropathy Rapid Response January 22, 2021 View PDF
Last Updated : May 18, 2021